PBUS ETF Analysis: PureBeta USA | BATS

Large Blend | BATS, USA | Market Cap: 11.372m USD | 12M Return: 17% | Charts, Fundamentals & Technical Analysis

US Equities, Large Cap, Mid Cap, Index Tracking
Total Rating 55
Safety 45
Buy Signal -0.18
Large Blend
Category Rotation: -1.2
TER: 0.04%
AUM: 11.4B
Avg Turnover: 17.4M
Risk 3d forecast
Volatility13.5%
VaR 5th Pctl2.55%
VaR vs Median4.84%
Reward TTM
Sharpe Ratio0.96
Rel. Str. IBD48
Rel. Str. Peer Group44.7
Character TTM
Beta1.015
Beta Downside1.013
Hurst Exponent0.491
Drawdowns 3y
Max DD19.07%
CAGR/Max DD1.00
CAGR/Mean DD8.74

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 8.8 years of data

Jan -0.1% 0
Feb -2.0% 31
Mar -0.2% 11
Apr +1.0% 12
May +0.7% 2
Jun +0.7% 14
Jul +0.7% 22
Aug -0.3% 23
Sep -3.9% 21
Oct -1.6% 0
Nov +2.4% 16
Dec -1.0% 2

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: PBUS PureBeta USA

The Invesco PureBeta MSCI USA ETF (PBUS) seeks to track the performance of the MSCI USA index, which measures large- and mid-capitalization segments of the U.S. equity market. The fund invests at least 90% of its total assets in the securities that make up this index, which is compiled and maintained by MSCI Inc. The fund is structured as a non-diversified ETF and falls within the Large Blend category, providing broad exposure to established U.S. companies across multiple sectors.

Headlines to Watch Out For
  • US large-cap inflows expand PBUS assets under management
  • Fee compression intensifies on low-cost broad market ETFs
  • Invesco ETF segment revenue scales with PBUS AUM growth
What is the price of PBUS shares?

As of July 28, 2026, the stock is trading at USD 74.13 with a total of 39,550 shares traded. Over the past week, the price has changed by -0.36%, over one month by -0.27%, over three months by +3.76% and over the past year by +17.00%.

Current recommended Stop Loss: 73.10 (which is 1.4% or 1.3 ATR below the current price).

Is PBUS a buy, sell or hold?

PureBeta USA has no consensus analysts rating.